CClinicalTrials.gg
CompletedNCT03874039Updated Apr 20, 2022

Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis

An observational study in Healthy Adults, Atopic Dermatitis and Wearables, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-20.

Sponsored by Northwestern University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

Pilot study of a wearable gas and sweat skin sensor

Read the detailed description

The objective of this study is exploratory and deploys two wearable sweat and gas sensors which detect the composition of sweat proteins and volatile gases emitted from the skin in healthy subjects and patients with atopic dermatitis.

02

Conditions studied

  • Healthy Adults
  • Atopic Dermatitis
  • Wearables
  • Sweat Sensor
  • Gas Sensor
03

In context

Dermatitis, Atopic

1,419 studies on the registry are indexed under Dermatitis, Atopic; 258 are open to participants now.

This study's enrollment of 20 is below the median of 150 across 237 observational studies indexed under Dermatitis, Atopic.

Browse Dermatitis, Atopic studies →

Lead sponsor

Northwestern University is the lead sponsor of 1,396 studies on the registry; 199 are open to participants now.

Of its 102 completed or terminated interventional studies of FDA-regulated products, 73 (72%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy adults and adults with prior diagnosis of atopic dermatitis from made by board certified dermatologist

Inclusion criteria

  • Age ≥18 years old
  • Subjects willing and able to comply with requirements of the protocol
  • Healthy adults or subjects with atopic dermatitis

Exclusion criteria

Exclusion Criteria:

  • Age \<18 years old
  • Subjects unwilling and able to comply with requirements of the protocol
  • History of skin allergy to medical adhesive tape
  • History of heat stroke, heat related or exercise related
  • Non-English speaking subjects
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy Adults

    Healthy adults with no prior diagnosis of atopic dermatitis

    Device: Gas sensor · Device: Sweat Sensor

  • Atopic Dermatitis

    Adults with prior diagnosis of Atopic Dermatitis from board certified dermatologist

    Device: Gas sensor · Device: Sweat Sensor

Interventions

  • DeviceGas sensor

    The gas sensor is an airtight gas capsule attached with a floating solid phase microextraction (SPME) tube. SPME uses a fiber coated with a nontoxic liquid (polymer), and a nontoxic solid (sorbent). The fiber coating extracts the compounds from the gas being released from the skin. Only the glass sample is in contact with the skin.

  • DeviceSweat Sensor

    The sweat sensor is a soft, flexible device that rests on the skin and collects secreted sweat through capillary action. The device is held in place by medical-grade acrylic adhesive film.

06

What researchers measure

Primary outcomes

  1. Evaluation of gas exudates

    Evaluation of protein contents from gas exudates from the skin

    Time frame: 20 minutes

  2. Evaluation of sweat proteins

    Evaluation of protein contents from sweat from the skin

    Time frame: 20 minutes

07

Study locations

1 site
  • Northwestern University
    Chicago, Illinois 60610-5402, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03874039
Lead sponsor
Northwestern University
Responsible party
Shuai (Steve) Xu (Principal Investigator, Northwestern University) — Principal investigator
First posted
Mar 14, 2019
Start date
Jan 15, 2019
Primary completion
Aug 10, 2021
Completion
Aug 10, 2021
Last update
Apr 20, 2022

Study contacts

Shuai Xu, MD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion